PHI IS OPENING A NEW DEVELOPMENT OFFICE IN THE US

Report this content

As a result of the newly created alliance for advancing cell-based biomanufacturing which was recently communicated, Phase Holographic Imaging (PHI) is taking the next step in its investment into regenerative medicine by opening an office in the Innovation Quarter in Winston-Salem.

The new office is in, what is called, the Regenerative Medicine Hub (RegenMed Hub™), where PHI will develop its non-invasive technology for cell quality control in the field of regenerative medicine. With this step, PHI will have access to Wake Forest Institute facilities and expertise to test and develop its non-invasive technology and to learn first-hand more about the present advances and in the field. To launch as soon as possible, PHI’s Chief Scientific Officer, Kersti Alm, will kick-start the office now mid-November.

For additional information, please contact:
Lisa Bodily

E-mail: ir@phiab.se
Web: www.phiab.com – Live cell imaging & analysis

Phase Holographic Imaging (PHI) develops instrumentation and software for time-lapse cytometry. The products are used for long-term quantitative analysis of the dynamics of live cells, particularly significant in the research of cancer, as well as in the treatment of inflammatory and autoimmune diseases. The products are sold globally through the company's distributors. The company is based in Lund, Sweden, and in Boston, Massachusetts.

Subscribe

Documents & Links